Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +10.98% | +32.41% | +9.09% |
Chart calendar Corvus Pharmaceuticals, Inc.
Upcoming events on Corvus Pharmaceuticals, Inc.
Past events on Corvus Pharmaceuticals, Inc.
2024-03-19 04:30 pm | Q4 2023 Earnings Call |
2024-03-19 04:02 pm | Q4 2023 Earnings Release |
2024-02-07 | Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No 4278 |
2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract No 1442 |
2023-11-07 04:30 pm | Q3 2023 Earnings Call |
2023-11-07 04:01 pm | Q3 2023 Earnings Release |
2023-09-07 08:30 am | CPI-818 Phase 3 Clinical Trial Results Call |
2023-08-08 04:30 pm | Q2 2023 Earnings Call |
2023-08-08 04:01 pm | Q2 2023 Earnings Release |
2023-06-28 | Japanese Cancer Association and American Association for Cancer Research Precision Cancer Medicine I |
2023-06-15 04:00 pm | Annual General Meeting |
2023-06-15 06:30 am | International Malignant Lymphoma Meeting - Abstract #: 193 |
2023-06-07 09:30 am | Jefferies Global Healthcare Conference |
2023-05-08 04:30 pm | Q1 2023 Earnings Call |
2023-05-08 04:01 pm | Q1 2023 Earnings Release |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No 1813 |
2023-03-28 | Whistler Global Summit |
2023-03-28 04:30 pm | Q4 2022 Earnings Call |
2023-03-28 04:05 pm | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -48,9 -50,0 2.2% | -43,8 -43,7 -0.12% | -38,6 -40,8 5.21% | -32,6 -36,9 11.78% | -23,4 -23,6 0.78% | -33,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -46,7 -46,9 0.52% | -6,00 -56,9 89.47% | -43,2 -42,9 -0.82% | -41,3 -42,3 2.36% | -27,0 -26,5 -1.89% | -32,9 |
Net income Million USD | Released Forecast Spread | -46,7 -46,9 0.52% | -6,00 -41,0 85.37% | -43,2 -42,9 -0.82% | -41,3 -42,3 2.36% | -27,0 -26,5 -1.82% | -33,1 |
EPS USD | Released Forecast Spread | -1,59 -1,57 -1.6% | -0,20 -1,39 85.61% | -1,03 -0,98 -4.75% | -0,89 -0,91 2.2% | -0,56 -0,55 -1.82% | -0,57 |
Announcement Date | 05/03/20 | 25/03/21 | 10/03/22 | 28/03/23 | 19/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,81 -8,94 23.84% | -7,41 -7,49 1.03% | -7,01 -8,11 13.49% | -12,5 -6,96 -79.1% | -5,67 -10,0 43.41% | -6,57 -6,23 -5.56% | -5,62 -5,97 5.75% | -5,56 -6,09 8.64% | -5,65 -5,83 3.11% | -6,41 | -7,09 | -8,28 | -9,08 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,24 -8,86 -4.29% | -8,30 -7,54 -10.04% | -8,36 -8,09 -3.42% | -14,8 -7,35 -101.77% | -9,82 -10,8 9.19% | -7,87 -7,42 -6.04% | -6,50 -6,48 -0.3% | -6,00 -5,53 -8.55% | -6,65 -6,15 -8.18% | -7,36 | -7,34 | -8,58 | -9,65 |
Net income Million USD | Released Forecast Spread | -9,24 -8,86 -4.29% | -8,30 -7,54 -10.04% | -8,36 -8,22 -1.74% | -14,8 -7,35 -101.77% | -9,82 -10,8 9.19% | -7,87 -7,42 -6.04% | -6,50 -6,48 -0.3% | -6,00 -5,98 -0.38% | -6,65 -6,17 -7.89% | -6,56 | -7,03 | -8,16 | -9,01 |
EPS USD | Released Forecast Spread | -0,20 -0,19 -7.14% | -0,18 -0,15 -17.39% | -0,18 -0,18 -1.88% | -0,32 -0,16 -104.25% | -0,21 -0,23 8.7% | -0,17 -0,16 -8.51% | -0,14 -0,14 0% | -0,12 -0,12 2.04% | -0,14 -0,13 -10.52% | -0,13 | -0,13 | -0,15 | -0,16 |
Announcement Date | 10/03/22 | 05/05/22 | 08/08/22 | 03/11/22 | 28/03/23 | 08/05/23 | 08/08/23 | 07/11/23 | 19/03/24 | - | - | - | - |
2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 01:00 am | VALNEVA: Q1 2024 Earnings Release |
2024-05-07 07:00 am | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Corvus Pharmaceuticals, Inc.
2024-05-02 04:10 pm | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | GALAPAGOS NV: Q1 2024 Earnings Release |
2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:05 am | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRVS Stock
- Calendar Corvus Pharmaceuticals, Inc.